//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
The ICR is making the discoveries that defeat cancer. We're a top UK academic research centre, a postgrad college, and a charity. 📍 London (Chelsea and Sutton) https://www.icr.ac.uk/
The Institute of Cancer Research









Loading...
He will also highlight the growing importance of computational approaches and machine learning/AI in areas such as target identification, druggability analysis (e.g. using canSAR), and hit discovery.
Professor Workman will share his insights on the incredible progress in discovering new precision cancer medicines, and how disruptive technologies are accelerating this progress. This includes advances in PROTACs, molecular glues and the critical role of biomarkers in patient selection.
🎤 We’re delighted that ICR's Professor Paul Workman is speaking on a panel today at The Galien Foundation Forum at the @sciencemuseum.org.uk where this year’s focus is Future Health Disrupted: From Discovery to Delivery.
More from here us ⬇️